Reply from the Authors: We appreciate Dr. Kyriakides' comments on our recent article. The issue of modifier factors in DMD probably involves multiple mechanisms.
As suggested by Dr. Kyriakides, we checked the expression of the utrophin (UTRN) mRNA querying our expression profiling data obtained from muscle biopsies of "mild" DMD (those patients with late loss of ambulation) and "severe" DMD (with early loss of ambulation). 1 UTRN mRNA was expressed at a level similar to controls in the patients with severe DMD (1.11 times), while it was downregulated in the patients with mild DMD (0.53 times). The t test-considering only skeletal muscle-specific genes (429 genes)-confirmed the differential expression of the UTRN between the 2 subsets of patients (p ϭ 0.026).
The utrophin protein is upregulated in DMD and its expression shows a positive correlation with age at biopsy and time to becoming wheelchair bound. 3 It has been shown that this upregulation is driven via translation mechanisms. 5 Utrophin transcripts are similar to those observed in normal muscle samples in human and mouse models of DMD (mdx mice). 4, 6, 7 Data on utrophin mRNA expression in DMD are inconclusive. Quantitative studies are limited and data are derived from a few patients with significant difference in age at biopsy. Robust measurement of utrophin mRNA needs to be conducted in a larger series of patients of similar age with welldefined clinical outcomes.
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Reply from the Editorialists: As suggested by Dr. Kyriakides, Pegoraro et al. 1 provide an interesting additional set of data on a much larger cohort of boys in regard to the role of UTRN mRNA upregulation as an ameliorating factor in DMD progression. In contrast to the prior study by Kleopas et al., 3 Pegoraro et al. identified that UTRN mRNA downregulation is associated with a milder disease course. Thus, the role of upregulation or downregulation of UTRN mRNA or protein in humans is still unclear. who provided interesting evidence of a pathologic process affecting the tunica media and adventitia as the nidus for cervical artery dissection. Their work appears to be consistent with coronary artery and thoracic aortic dissection. However, the authors do not discuss dissection of the intracranial arteries, where a different vascular layer may be affected depending on the nature of the presentation. These arteries are histologically different from extracranial arteries where the media is thinner and there is no external elastic lamina. 2 Patients with subarachnoid hemorrhage due to intracranial dissection may present with subarachnoid hemorrhage, where the plane of dissection is considered subadventitial; patients with ischemic stroke present with subintimal dissection. 3 It has been shown that patients with subintimal dissection and ischemia do not progress to hemorrhage even if treated with anticoagulation. 4 It would be interesting to know if the authors believe that their proposed pathogenic pathway would be applicable in intracranial dissection, whether presenting with ischemia or hemorrhage.
Due to the different morphology of the arteries, it is possible that a different pathogenic process is occurring in intracranial artery dissection. Reply from the Authors: We thank Dr. Willey for his comments. We did not mention intracranial dissections because we did not examine superficial temporal artery biopsies of patients with intracranial dissection. However, we think that the pathophysiologic mechanisms of dissection may be different.
The key point is the different anatomy of intradural arteries so it may be preferable to differentiate between extradural and intradural dissections instead of extracranial and intracranial dissections. Dr. Willey mentioned that these arteries have an up to 30% thinner tunica muscularis and tunica adventitia and a missing lamina elastica externa. 5 In autopsy studies, both mechanisms of subintimal dissection and subadventitial dissection have been described. 6, 7 The clinical consequences of an arterial occlusion in case of a subintimal dissection and arterial rupture in case of a subadventitial dissection correspond to these different pathophysiologic mechanisms. 8 However, we think that no firm conclusions can be drawn from these findings in a small patient series.
